論文・書籍PUBLICATIONS

2016年

  1. Hiramatsu M, Hishikawa T, Tokunaga K, Kidoya H, Nishihiro S, Haruma J, Shimizu T, Takasugi Y, Shinji Y, Sugiu K, Takakura N, Date I. "Combined gene therapy with vascular endothelial growth factor plus apelin in a chronic cerebral hypoperfusion model in rats"
    J Neurosurg. 2016 Dec 23:1-8.
  2. Yamane K, Naito H, Wakabayashi T, Yoshida H, Muramatsu F, Iba T, Kidoya H, Takakura N. "Regulation of SLD5 gene expression by miR-370 during acute growth of cancer cells"
    Sci Rep. 2016 Aug 8;6:30941.
  3. Kanzaki R, Naito H, Kise K, Takara K, Eino D, Minami M, Shintani Y, Funaki S, Kawamura T, Kimura T, Okumura M, Takakura N. "PSF1 (Partner of SLD Five 1) is a Prognostic Biomarker in Patients with Non-small Cell Lung Cancer Treated with Surgery Following Preoperative Chemotherapy or Chemoradiotherapy" Ann Surg Oncol. 2016 Nov;23(12): 4093-4100.
  4. Naito H, Wakabayashi T, Kidoya H, Muramatsu F, Takara K, Eino D, Yamane K, Iba T, Takakura N. "Endothelial Side Population Cells Contribute to Tumor Angiogenesis and Antiangiogenic Drug Resistance" Cancer Res. 2016 Jun 1;76(11):3200-10.
  5. Phanthanawiboon S, Limkittikul K, Sakai Y, Takakura N, Saijo M, Kurosu T. "Acute Systemic Infection with Dengue Virus Leads to Vascular Leakage and Death through Tumor Necrosis Factor-α and Tie2/Angiopoietin Signaling in Mice Lacking Type I and II Interferon Receptors" PLoS One. 2016 Feb 4;11(2):e0148564.
  6. Zhang L, Takara K, Yamakawa D, Kidoya H, Takakura N. "Apelin as a marker for monitoring the tumor vessel normalization window during antiangiogenic therapy"
    Cancer Sci. 2016 Jan;107(1):36-44.
PAGETOP